We have located links that may give you full text access.
The Risk of Developing Obesity, Insulin Resistance, and Metabolic Syndrome in Former Power-sports Athletes - Does Sports Career Termination Increase the Risk.
Introduction: Obesity is associated with several complications like metabolic syndrome. Many professional athletes adopt a sedentary lifestyle after retirement. This study was aimed at assessing the risk of developing obesity, insulin resistance (IR), and metabolic syndrome among former power-sports athletes, compared with age-matched active athletes and nonathletes.
Materials and Methods: The study was conducted in Mashhad during 2012-2014. The individuals were recruited through announcements and were divided into three groups of active athletes ( n = 34), ex-athletes ( n = 30), and nonathletes ( n = 30). Demographic and anthropometric data were collected and biochemical factors including low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol, triglycerides (TG), fasting plasma glucose, insulin, and high-sensitive C-reactive protein were measured.
Results: Ex-athletes had significantly higher mean values of weight, body mass index, diastolic blood pressure, LDL-C, insulin, homeostatic model assessment (HOMA) IR, and HOMA β-cell function (HOMA-%β-cell) compared with active athletes and nonathletes ( P < 0.001, P < 0.001, P < 0.001, P = 0.03, P = 0.01, P = 0.02, and P = 0.01, respectively). However, mean values of HDL-C was significantly lower in ex-athletes compared with nonathletes ( P < 0.001). The prevalence of metabolic syndrome showed no significant difference among three groups, although its mean was higher among ex-athletes.
Conclusions: The results showed that abandoning regular athletic exercise and weight cycling in power sports athletes leads to adverse outcomes such as obesity and IR. Although higher IR might not necessarily result in metabolic syndrome in short term, it could cause metabolic syndrome in the long run.
Materials and Methods: The study was conducted in Mashhad during 2012-2014. The individuals were recruited through announcements and were divided into three groups of active athletes ( n = 34), ex-athletes ( n = 30), and nonathletes ( n = 30). Demographic and anthropometric data were collected and biochemical factors including low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol, triglycerides (TG), fasting plasma glucose, insulin, and high-sensitive C-reactive protein were measured.
Results: Ex-athletes had significantly higher mean values of weight, body mass index, diastolic blood pressure, LDL-C, insulin, homeostatic model assessment (HOMA) IR, and HOMA β-cell function (HOMA-%β-cell) compared with active athletes and nonathletes ( P < 0.001, P < 0.001, P < 0.001, P = 0.03, P = 0.01, P = 0.02, and P = 0.01, respectively). However, mean values of HDL-C was significantly lower in ex-athletes compared with nonathletes ( P < 0.001). The prevalence of metabolic syndrome showed no significant difference among three groups, although its mean was higher among ex-athletes.
Conclusions: The results showed that abandoning regular athletic exercise and weight cycling in power sports athletes leads to adverse outcomes such as obesity and IR. Although higher IR might not necessarily result in metabolic syndrome in short term, it could cause metabolic syndrome in the long run.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app